Edition:
United Kingdom

ProQR Therapeutics NV (PRQR.OQ)

PRQR.OQ on NASDAQ Stock Exchange Global Market

3.00USD
18 Jan 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.00
Open
$3.00
Day's High
$3.05
Day's Low
$3.00
Volume
14,602
Avg. Vol
31,310
52-wk High
$6.85
52-wk Low
$2.78

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.33 -0.416
Jun '17 0.26 -0.474
Mar '17 0.39 -0.446
FY 2016 Dec '16 0.10 -0.378
Sep '16 0.45 -0.434
Jun '16 0.59 -0.427
Mar '16 0.69 -0.437
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 0.56 1.11 0.00 2.56
Earnings (per share)
Year Ending Dec-18 2 -1.54 -1.30 -1.78 -2.01
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.75 32.90
P/E High - Last 5 Yrs. -- 302.25 46.03
P/E Low - Last 5 Yrs. -- 94.23 24.39
Beta -- 0.88 0.89
Price to Sales (TTM) 79.24 94.46 5.41
Price to Book (MRQ) 2.60 13.37 5.38
Price to Tangible Book (MRQ) 2.61 13.65 6.89
Price to Cash Flow (TTM) -- 72.91 23.43
% Owned Institutions 54.62 11.52 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.51
Dividend 5 Year Growth Rate -- 1.72 5.23
Payout Ratio(TTM) -- 16.23 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.01 401.35 9.01
Sales (TTM) vs TTM 1 Yr. Ago -64.75 70.94 5.44
Sales - 5 Yr. Growth Rate -- 33.11 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.03 29.52 19.33
EPS (TTM) vs TTM 1 Yr. Ago -24.00 -- --
EPS - 5 Yr. Growth Rate -- 40.23 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.36 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 8.22 5.22 2.97
LT Debt to Equity (MRQ) 16.54 21.07 12.10
Total Debt to Equity (MRQ) 16.54 22.62 16.38
Interest Coverage (TTM) -- -102.11 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.23 54.86
Gross Margin - 5 Yr. Avg. -- 52.57 52.45
EBITD Margin (TTM) -3,241.64 -- --
EBITD - 5 Yr. Avg -- -239.65 15.33
Operating Margin (TTM) -3,331.95 -519.48 7.74
Operating Margin - 5 Yr. Avg. -- -256.84 10.79
Pre-Tax Margin (TTM) -3,376.41 -495.13 8.53
Pre-Tax Margin - 5 Yr. Avg. -- -256.77 11.19
Net Profit Margin (TTM) -3,376.57 -496.63 4.84
Net Profit Margin - 5 Yr. Avg. -- -259.99 7.50
Effective Tax Rate (TTM) -- 23.31 23.05
Effective Tax Rate - 5 Yr. Avg. -- 18.78 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 10,657 23,331,032 855,738,258
Net Income/Employee (TTM) -359,831 3,081,067 100,666,768
Receivable Turnover (TTM) -- 20.25 5.76
Inventory Turnover (TTM) -- 2.31 3.34
Asset Turnover (TTM) 0.02 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -61.65 0.10 10.97
Return on Assets - 5 Yr. Avg. -- 0.51 12.39
Return on Investment (TTM) -68.51 3.21 14.40
Return on Investment - 5 Yr. Avg. -- 3.64 16.20
Return on Equity (TTM) -75.74 4.54 16.09
Return on Equity - 5 Yr. Avg. -- 8.99 17.53
  1 Year 3 Year 5 Year
Sales % -43.49 150.71 --
EPS (TTM) % -87.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ProQR Therapeutics NV

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.24%
# of Holders: 38
Total Shares Held: 14,732,345
3 Mo. Net Change: 260
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.